Yingcai Niu
-
- Medicinal Plants and Neuroprotection 5
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection 5
- Neurology top 5%
- Hepatology top 5%
- Liver physiology and pathology 9
- Biochemistry top 10%
-
- Liver Disease Diagnosis and Treatment 8
-
- Alzheimer's disease research and treatments 7
-
- Genomics, phytochemicals, and oxidative stress 6
-
- Heavy Metal Exposure and Toxicity 6
-
- Sunflower and Safflower Cultivation 4
- Partner nations
- ChinaUnited States
In The Last Decade
Yingcai Niu
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Complementary and alternative medicine 303
- Pharmacology 174
- Neurology 159
- Hepatology 128
- Biochemistry 78
Countries citing papers authored by Yingcai Niu
This map shows the geographic impact of Yingcai Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingcai Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingcai Niu more than expected).
Fields of papers citing papers by Yingcai Niu
This network shows the impact of papers produced by Yingcai Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingcai Niu. The network helps show where Yingcai Niu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingcai Niu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 22 | |
| 4 | 2021 | 42 | |
| 5 | 2020 | 13 | |
| 6 | 2020 | 25 | |
| 7 | 2018 | 75 | |
| 8 | 2017 | 13 | |
| 9 | 2017 | 38 | |
| 10 | 2016 | 18 | |
| 11 | 2015 | 34 | |
| 12 | 2014 | 2 | |
| 13 | 2014 | 46 | |
| 14 | 2014 | 47 | |
| 15 | 2012 | 27 | |
| 16 | Beta-asarone attenuates beta-amyloid-induced apoptosis through the inhibition of the activation of apoptosis signal-regulating kinase 1 in SH-SY5Y cells. | 2011 | 31 |
| 17 | 2011 | 79 | |
| 18 | 2010 | 63 | |
| 19 | 2010 | 41 | |
| 20 | 2010 | 74 |
About Yingcai Niu
Yingcai Niu is a scholar working on Hepatology, Pharmacology and Complementary and alternative medicine, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Alzheimer's disease research and treatments (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Heavy Metal Exposure and Toxicity (6 papers), Medicinal Plants and Neuroprotection (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Sunflower and Safflower Cultivation (4 papers). The work is most often cited by research in Complementary and alternative medicine (303 citations), Pharmacology (174 citations) and Neurology (159 citations). Yingcai Niu has collaborated with scholars based in China and United States. Frequent co-authors include Miaoxian Dong, Zhou Li, Jicheng Liu, Chengchong Li, Guihua Xing, Xiaoming Li, Chunlei Yu, Xuemei Zhao, Yu Zou and Rong Hua.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.